PEDIATRICS Vol. 73 No. 1 January 1984, pp. 114-115
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ACKERMAN, A.
Right arrow Articles by RODMAN, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ACKERMAN, A.
Right arrow Articles by RODMAN, D.

Azarcón and Empacho

ALAN ACKERMAN PHD1 and DOROTHY RODMAN RN1

1 Sunrise Community Health Center, 1028-5th Ave, PO Box 245, Greeley, CO 80632

To the Editor.—

We were pleased to see the case report concerning azarcó-related lead poisoning from the treatment of empacho.1 Since the time Bose et al composed their paper (September 1982), several new pieces of information have become available.

1. Additional cases of azarcó poisoning have been confirmed in Michigan-four cases, Wisconsin—one case, and California—ten cases.2-4 In several of these cases, other children in the extended family have either died of seizures after receiving azarcón in Mexico—one case5 or had been chelated for lead poisoning several years previously, although no source of lead had been identified—one case.3